BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sanjo A, Satoi J, Ohnishi A, Maruno J, Fukata M, Suzuki N. Role of elevated platelet-associated immunoglobulin G and hypersplenism in thrombocytopenia of chronic liver diseases. J Gastroenterol Hepatol. 2003;18:638-644. [PMID: 12753144 DOI: 10.1046/j.1440-1746.2003.03026.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Xianghong G, Guanping C, Fenghua Y, Jiayin W. Changes in platelet functional parameters and CD62 P expression in liver cirrhosis. Afr Health Sci 2013;13:1079-83. [PMID: 24940335 DOI: 10.4314/ahs.v13i4.31] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
2 Aref S, Sleem T, El Menshawy N, Ebrahiem L, Abdella D, Fouda M, Samara NA, Menessy A, Abdel-Ghaffar H, Bassam A. Antiplatelet antibodies contribute to thrombocytopenia associated with chronic hepatitis C virus infection. Hematology. 2009;14:277-281. [PMID: 19843383 DOI: 10.1179/102453309x439818] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
3 Marks KM, Clarke RM, Bussel JB, Talal AH, Glesby MJ. Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy. J Acquir Immune Defic Syndr 2009;52:595-9. [PMID: 19734800 DOI: 10.1097/QAI.0b013e3181b79aff] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
4 Weksler BB. Review article: the pathophysiology of th-rombocytopenia in hepatitis C virus infection and chronic liver disease. Aliment Pharmacol Ther. 2007;26 Suppl 1:13-19. [PMID: 17958515 DOI: 10.1111/j.1365-2036.2007.03512.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 4.9] [Reference Citation Analysis]
5 Lv Y, Lau WY, Li Y, Deng J, Han X, Gong X, Liu N, Wu H. Hypersplenism: History and current status. Exp Ther Med 2016;12:2377-82. [PMID: 27703501 DOI: 10.3892/etm.2016.3683] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 4.2] [Reference Citation Analysis]
6 Watanabe Y, Horiuchi A, Yoshida M, Yamamoto Y, Sugishita H, Kumagi T, Hiasa Y, Kawachi K. Significance of laparoscopic splenectomy in patients with hypersplenism. World J Surg. 2007;31:549-555. [PMID: 17308852 DOI: 10.1007/s00268-006-0504-8] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
7 Zermatten MG, Fraga M, Moradpour D, Bertaggia Calderara D, Aliotta A, Stirnimann G, De Gottardi A, Alberio L. Hemostatic Alterations in Patients With Cirrhosis: From Primary Hemostasis to Fibrinolysis. Hepatology 2020;71:2135-48. [PMID: 32090357 DOI: 10.1002/hep.31201] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
8 Kato M, Shimohashi N, Ouchi J, Yoshida K, Tanabe Y, Takenaka K, Nakamuta M. Partial splenic embolization facilitates completion of interferon therapy in patients with chronic HCV infection and hypersplenism. J Gastroenterol. 2005;40:1076-1077. [PMID: 16322955 DOI: 10.1007/s00535-005-1693-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
9 Tillmann HL, McHutchison JG. Use of thrombopoietic agents for the thrombocytopenia of liver disease. Semin Hematol 2010;47:266-73. [PMID: 20620438 DOI: 10.1053/j.seminhematol.2010.04.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
10 Speth C, Löffler J, Krappmann S, Lass-flörl C, Rambach G. Platelets as immune cells in infectious diseases. Future Microbiology 2013;8:1431-51. [DOI: 10.2217/fmb.13.104] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 6.5] [Reference Citation Analysis]
11 Stasi R, Chia LW, Kalkur P, Lowe R, Shannon MS. Pathobiology and treatment of hepatitis virus-related thrombocytopenia. Mediterr J Hematol Infect Dis 2009;1:e2009023. [PMID: 21415958 DOI: 10.4084/MJHID.2009.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
12 Rawi S, Wu GY. Pathogenesis of Thrombocytopenia in Chronic HCV Infection: A Review. J Clin Transl Hepatol 2020;8:184-91. [PMID: 32832399 DOI: 10.14218/JCTH.2020.00007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Jacobs EJ, Newton CC, Silverman DT, Nogueira LM, Albanes D, Männistö S, Pollak M, Stolzenberg-Solomon RZ. Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studies. Cancer Causes Control 2014;25:1083-91. [PMID: 24913781 DOI: 10.1007/s10552-014-0409-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
14 Ikarashi Y, Kodama K, Taniai M, Hashimoto E, Tokushige K. The Clinical Difference in the Platelet Counts between Liver Cirrhosis with Nonalcoholic Fatty Liver Disease and Hepatitis C Virus. Intern Med 2018;57:1065-70. [PMID: 29269684 DOI: 10.2169/internalmedicine.9853-17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
15 Lin KH, Hsu PI, Yu HC, Lin CK, Tsai WL, Chen WC, Chan HH, Lai KH. Factors linked to severe thrombocytopenia during antiviral therapy in patients with chronic hepatitis c and pretreatment low platelet counts. BMC Gastroenterol 2012;12:7. [PMID: 22257364 DOI: 10.1186/1471-230X-12-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
16 Aref S, Ibrahem L, El Menshawy N, Bassam A. Effect of splenectomy on platelets associated antibodies in hepatitis C patients with thrombocytopenia. Hematology 2012;17:118-21. [PMID: 22664051 DOI: 10.1179/102453312X13221316477705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Feltracco P, Brezzi M, Barbieri S, Galligioni H, Milevoj M, Carollo C, Ori C. Blood loss, predictors of bleeding, transfusion practice and strategies of blood cell salvaging during liver transplantation. World J Hepatol. 2013;5:1-15. [PMID: 23383361 DOI: 10.4254/wjh.v5.i1.1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
18 Zahn A, Jennings N, Ouwehand WH, Allain JP. Hepatitis C virus interacts with human platelet glycoprotein VI. J Gen Virol 2006;87:2243-51. [PMID: 16847120 DOI: 10.1099/vir.0.81826-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
19 Mitchell O, Feldman DM, Diakow M, Sigal SH. The pathophysiology of thrombocytopenia in chronic liver disease. Hepat Med. 2016;8:39-50. [PMID: 27186144 DOI: 10.2147/hmer.s74612] [Cited by in Crossref: 18] [Cited by in F6Publishing: 42] [Article Influence: 3.6] [Reference Citation Analysis]
20 Violi F, Basili S, Raparelli V, Chowdary P, Gatt A, Burroughs AK. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? J Hepatol 2011;55:1415-27. [PMID: 21718668 DOI: 10.1016/j.jhep.2011.06.008] [Cited by in Crossref: 107] [Cited by in F6Publishing: 81] [Article Influence: 10.7] [Reference Citation Analysis]
21 Nwokediuko SC, Ibegbulam O. Quantitative Platelet Abnormalities in Patients With Hepatitis B Virus-Related Liver Disease. Gastroenterology Res 2009;2:344-9. [PMID: 27990204 DOI: 10.4021/gr2009.12.1329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
22 Witters P, Freson K, Verslype C, Peerlinck K, Hoylaerts M, Nevens F, Van Geet C, Cassiman D. Review article: Blood platelet number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther. 2008;27:1017-1029. [PMID: 18331464 DOI: 10.1111/j.1365-2036.2008.03674.x] [Cited by in Crossref: 102] [Cited by in F6Publishing: 82] [Article Influence: 7.8] [Reference Citation Analysis]
23 Iga D, Tomimatsu M, Endo H, Ohkawa S, Yamada O. Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon-alpha therapy: possible etiology of HCV-associated immune thrombocytopenia. Eur J Haematol. 2005;75:417-423. [PMID: 16191092 DOI: 10.1111/j.1600-0609.2005.00524.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
24 El-sayed R, El-ela MA, El-raziky MS, Helmy H, El-ghaffar AA, El-karaksy H. Relation of Serum Levels of Thrombopoietin to Thrombocytopenia in Extrahepatic Portal Vein Obstruction Versus Cirrhotic Children. Journal of Pediatric Hematology/Oncology 2011;33:e267-70. [DOI: 10.1097/mph.0b013e31821d80be] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
25 Jin W, Deng L, Zhang Q, Lin D, Zhu J, Chen Y, Chen B, Li J. A canine portal hypertension model induced by intra-portal administration of Sephadex microsphere. J Gastroenterol Hepatol. 2010;25:778-785. [PMID: 20492334 DOI: 10.1111/j.1440-1746.2009.06158.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
26 Karakan T, Cindoruk M, Degertekin B, Dogan I, Sancak A, Dumlu S, Gorgul A, Unal S. Combination therapy with pegylated interferon plus ribavirin in the treatment of hepatitis C virus-related thrombocytopenia. Curr Ther Res Clin Exp 2005;66:247-53. [PMID: 24764593 DOI: 10.1016/j.curtheres.2005.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Ohira M, Ishifuro M, Ide K, Irei T, Tashiro H, Itamoto T, Ito K, Chayama K, Asahara T, Ohdan H. Significant correlation between spleen volume and thrombocytopenia in liver transplant patients: a concept for predicting persistent thrombocytopenia. Liver Transpl. 2009;15:208-215. [PMID: 19177451 DOI: 10.1002/lt.21663] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
28 Sekiguchi T, Nagamine T, Takagi H, Mori M. Autoimmune thrombocytopenia in response to splenectomy in cirrhotic patients with accompanying hepatitis C. World J Gastroenterol 2006;12:1205-10. [PMID: 16534872 DOI: 10.3748/wjg.v12.i8.1205] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
29 Saif-Al-Islam M, Abdelaal UM, Younis MA, Alghany Algahlan HA, Khalaf S. Effect of Direct-Acting Antiviral Therapy on Thrombocytopenic Patients with Hepatitis C Virus-Related Chronic Liver Disease. Gastroenterol Res Pract 2021;2021:8811203. [PMID: 34122539 DOI: 10.1155/2021/8811203] [Reference Citation Analysis]
30 Saleh MI, Obeidat AR, Anter HA, Khanfar AA. Eltrombopag dose predictors in thrombocytopenic subjects with hepatitis C virus infection. Clin Exp Pharmacol Physiol 2015;42:1030-5. [DOI: 10.1111/1440-1681.12451] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
31 van Dievoet MA, Eeckhoudt S, Stephenne X. Primary Hemostasis in Chronic Liver Disease and Cirrhosis: What Did We Learn over the Past Decade? Int J Mol Sci 2020;21:E3294. [PMID: 32384725 DOI: 10.3390/ijms21093294] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Matsuura T, Hayashida M, Saeki I, Taguchi T. The risk factors of persistent thrombocytopenia and splenomegaly after liver transplantation. Pediatr Surg Int 2010;26:1007-10. [DOI: 10.1007/s00383-010-2660-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
33 Honda M, Yamamoto H, Hayashida S, Suda H, Ohya Y, Lee KJ, Takeichi T, Asonuma K, Inomata Y. Factors predicting persistent thrombocytopenia after living donor liver transplantation in pediatric patients. Pediatr Transplant 2011;15:601-5. [PMID: 21790916 DOI: 10.1111/j.1399-3046.2011.01533.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Fayed NA, Abdallah AR, Khalil MK, Marwan IK. Therapeutic rather than prophylactic platelet transfusion policy for severe thrombocytopenia during liver transplantation. Platelets 2014;25:576-86. [PMID: 24246132 DOI: 10.3109/09537104.2013.849335] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
35 Kujovich JL. Hemostatic defects in end stage liver disease. Crit Care Clin. 2005;21:563-587. [PMID: 15992673 DOI: 10.1016/j.ccc.2005.03.002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
36 Aref S, Mabed M, Selim T, Goda T, Khafagy N. Thrombopoietin (TPO) levels in hepatic patients with thrombocytopenia. Hematology. 2004;9:351-356. [PMID: 15763973 DOI: 10.1080/10245330400010620] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
37 Temel T, Cansu DU, Temel HE, Ozakyol AH. Serum thrombopoietin levels and its relationship with thrombocytopenia in patients with cirrhosis. Hepat Mon 2014;14:e18556. [PMID: 24976834 DOI: 10.5812/hepatmon.18556] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
38 de Almeida AJ, Campos-de-Magalhães M, Antonietti CL, Brandão-Mello CE, da Silva ML, de Oliveira RV, do Espírito-Santo MP, Yoshida CF, Lampe E. Autoimmune thrombocytopenia related to chronic hepatitis C virus infection. Hematology 2009;14:49-58. [PMID: 19154665 DOI: 10.1179/102453309X385106] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
39 Dou J, Lou Y, Wu J, Lu Y, Jin Y. Thrombocytopenia in patients with hepatitis B virus-related chronic hepatitis: evaluation of the immature platelet fraction. Platelets. 2014;25:399-404. [PMID: 24047408 DOI: 10.3109/09537104.2013.832742] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
40 Tana MM, Zhao X, Bradshaw A, Moon MS, Page S, Turner T, Rivera E, Kleiner DE, Heller T. Factors associated with the platelet count in patients with chronic hepatitis C. Thromb Res. 2015;135:823-828. [PMID: 25728497 DOI: 10.1016/j.thromres.2015.02.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
41 Alzubiedi S, Saleh MI. Predictors of Severe Thrombocytopenia Secondary to Peginterferon Alfa-2a Treatment in Subjects With Hepatitis C Virus Infection. American Journal of Therapeutics 2017;24:e670-5. [DOI: 10.1097/mjt.0000000000000356] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]